Letter to the editor: Pitfalls in the outcome differences between NAFLD and MAFLD
- PMID: 35532891
- DOI: 10.1002/hep.32563
Letter to the editor: Pitfalls in the outcome differences between NAFLD and MAFLD
Comment on
-
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?Hepatology. 2022 Nov;76(5):1423-1437. doi: 10.1002/hep.32499. Epub 2022 May 2. Hepatology. 2022. PMID: 35363908
References
REFERENCES
-
- Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcomes differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022. https://doi.org/10.1002/hep.32499
-
- Attia D, Aty NA, Shawket A, Said E, Fouad Y. MAFLD not NAFLD is associated with impairment of health-related quality of life. J Clin Transl Hepatol. 2022;10(1):4-5.
-
- Ayada I, van Kleef LA, Alferink LJM, Li P, de Knegt RJ, Pan Q. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups. Liver Int. 2022;42(2):277-87.
-
- Alharthi J, Gastaldelli A, Cua IH, Ghazinian H, Eslam M. Metabolic dysfunction-associated fatty liver disease: a year in review. Curr Opin Gastroenterol. 2022. https://doi.org/10.1097/MOG.0000000000000823
-
- Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488-95.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
